PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Second Department of Medical Oncology, General Oncology Hospital of Kifissia \'Agioi Anargiroi\', Athens, Nea Kifissia, Greece. d_lambropoulou@yahoo.gr.\', \'Second Department of Medical Oncology, General Oncology Hospital of Kifissia \'Agioi Anargiroi\', Athens, Nea Kifissia, Greece.\', \'Department of Anatomy and Surgical Anatomy, Medical School, National and Kapodistrian University of Athens, Athens, Greece.\', \'Laboratory of Biology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3855/jidc.15386
?:doi
?:hasPublicationType
?:journal
  • Journal of infection in developing countries
is ?:pmid of
?:pmid
?:pmid
  • 35192527
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.704
?:rankingScore_hIndex
  • 38
is ?:relation_isRelatedTo_publication of
?:title
  • The potential role of the combined PARP-1 and VEGF inhibition in severe SARS-CoV-2 (COVID-19) infection.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all